Jeffrey S Johnson, Mayer N Fishman, Michael J Schell, Xiaoqing Yu, Xuefeng Wang, Gabriel Roman Souza, Justin Miller, Sarah Raymond Mizelle, Keerthi Gullapalli, Adnan Nazir Fazili, Christopher Guske, Gowtam Mannam, Ghazal Jameel, Ling Cen, Jiqiang Yao, Junmin Whiting, Jennifer Swank, Jingsong Zhang, Philippe E. Spiess, Jad Chahoud. "Updated efficacy, safety, and correlative analysis of a phase II trial in metastatic renal cell carcinoma with coordinated pembrolizumab and high dose IL-2.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.554